Press

Deep Lens Announces Availability of Real Time Feasibility Solution

Columbus, OH – December 7, 2021 – Deep Lens, a digital healthcare company focused on revolutionizing the ...
Read More

Deep Lens and Southern Oncology Specialists Enter Strategic Partnership

COLUMBUS, OH AND CHARLOTTE, NC. – October 28, 2021 -- Southern Oncology Specialists and Deep Lens today ...
Read More

Deep Lens and Ocala Oncology/Florida Cancer Affiliates Collaborate to Expand Clinical Research Program with AI-Based Trial Matching Solution

COLUMBUS, Ohio, and OCALA, Florida -- October 20, 2021 – Ocala Oncology/Florida Cancer Affiliates and Deep ...
Read More

Deep Lens and Pacific Cancer Care Enter Strategic Partnership to Improve Clinical Trial Matching for Oncology Patients

COLUMBUS, Ohio, and MONTEREY, CA -- October 8, 2021 -- Pacific Cancer Care and Deep Lens today announced that ...
Read More

TD2 and Deep Lens Partner to Enable Diversity, Access and Faster Clinical Trial Enrollment for Community Oncology Practices

Key Partnership Will Connect Patients with Precision Oncology Clinical Trials and Novel Therapies, ...
Read More

BEVERLY HILLS CANCER CENTER AND DEEP LENS PARTNER

BEVERLY HILLS CANCER CENTER AND DEEP LENS PARTNER TO INTEGRATE NOVEL AI-BASED CLINICAL TRIAL MATCHING ...
Read More

Innovative Community Oncology Practices Selects Deep Lens' VIPER as Preferred Clinical Trial Matching Solution for Network

COLUMBUS, OH. and CANTON, OH. -- July 30, 2021 --- Deep Lens and the Innovative Community Oncology Practices ...
Read More

Breaking Down Barriers to Oncology Clinical Trial Enrollment Via Artificial Intelligence

Our Chief Scientific Officer and Co-Founder here at Deep Lens, TJ Bowen, recently wrote this article for The ...
Read More

Central Care Cancer Center & Deep Lens Partner to integrate AI-Matching solution VIPER™

COLUMBUS, Ohio, and SALINA, Kansas -- July 23, 2021 -- Central Care Cancer Center and Deep Lens today ...
Read More

Cancer & Blood Speciality Clinic Adopts Deep Lens Clinical Trial Matching Solution VIPER™

COLUMBUS, Ohio, and Los Alamitos, CA - July 7, 2021 - The Cancer and Blood Specialty Clinic (CBSC) and Deep ...
Read More

Dayton Physicians Network Adopts Deep Lens’ Novel Clinical Trial Matching Solution, VIPER, Broadening Research Program And Offering To Patients

By The Editors at Uncommon Conversations, March 10, 2020 COLUMBUS, Ohio, and DAYTON, Ohio -- June 29, 2021 -- ...
Read More

How AI technology can democratize clinical trials in oncology

Our Chief Scientific Officer and Co-Founder here at Deep Lens, TJ Bowen, recently wrote this article for ...
Read More

National Cancer Care Alliance Partners With Deep Lens

NATIONAL CANCER CARE ALLIANCE PARTNERS WITH DEEP LENS TO POSITION AI-BASED CLINICAL TRIAL MATCHING SOLUTION ...
Read More

New AI-Based Clinical Trial Matching Solution, Deep Lens’ Viper™, Expanding Offering to Cancer Patients at Norton Healthcare

COLUMBUS, Ohio--(BUSINESS WIRE)--Deep Lens today announced a collaboration that will integrate Deep Lens’ ...
Read More

The Center for Cancer & Blood Disorders Adopts Novel AI-Matching Solution VIPER™ to Expand Clinical Trial Program

COLUMBUS, Ohio, & FORT WORTH, Texas--(BUSINESS WIRE)--The Center for Cancer and Blood Disorders (The ...
Read More

New Mexico Cancer Center Expands Clinical Trial Offering By Adopting AI-Clinical Trial Matching Solution VIPER

COLUMBUS, Ohio, and ALBUQUERQUE -- May 26, 2021 -- New Mexico Cancer Center (NMCC) and Deep Lens today ...
Read More

New England Cancer Specialists Adopt Deep Lens’ Clinical Trial Matching Solution VIPER™ to Expand Clinical Trial Offering

COLUMBUS, Ohio & SCARBOROUGH, Maine--(BUSINESS WIRE)--Deep Lens and New England Cancer Specialists (NECS) ...
Read More

Oncology and Hematology Specialists, P.A. and Deep Lens Partner to Integrate Clinical Trial Matching Solution VIPER™ Into Network, Expanding Offering to Patients

COLUMBUS, Ohio & MORRISTOWN, NJ.--(BUSINESS WIRE)--Deep Lens and Oncology and Hematology Specialists, ...
Read More

Altru Health System Strengthens Clinical Trial Offering by Adopting Deep Lens’ Novel AI-Matching Solution, VIPER™

COLUMBUS, Ohio & GRAND FORKS, N.D.--(BUSINESS WIRE)--Deep Lens and Altru Health System today announced a ...
Read More

Alabama Oncology Adopts Deep Lens’ VIPER™ to Expand Clinical Trial Offering to Patient Community

COLUMBUS, Ohio & BIRMINGHAM, Ala.--(BUSINESS WIRE)--Deep Lens and Alabama Oncology today announced that ...
Read More

Oregon Oncology Specialists Integrate AI-screening Solution VIPER™

COLUMBUS, Ohio & SALEM, Ore.--(BUSINESS WIRE)--Deep Lens and Oregon Oncology Specialists today announced ...
Read More

Cardinal Health Launches Navista™ TS to Help Oncology Practices Improve Patient Care, Lower Costs and Drive Success in Value-Based Care

DUBLIN, Ohio, April 7, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) Specialty Solutions today launched ...
Read More

Hawaii Cancer Care Deploys Deep Lens’ AI-Screening Tool VIPER™ to Expand Clinical Trial Offering to patients

COLUMBUS, Ohio, and HONOLULU -- April 6, 2021 -- Hawaii Cancer Care and Deep Lens today announced a ...
Read More

PCR Oncology Expands Clinical Trial Offering by Adopting Deep Lens AI-Solution, VIPER

COLUMBUS, Ohio & ARROYO GRANDE, Calif.--(BUSINESS WIRE)--PCR Oncology and Deep Lens today announced a ...
Read More

Solano Hematology Oncology Adopts Deep Lens’ VIPER™ to Improve Patient Access to Clinical Trials

Published on February 24, 2021 COLUMBUS, Ohio, & VALLEJO, Calif. — Solano Hematology Oncology and Deep ...
Read More

Broome Oncology Selects Deep Lens’ VIPER™ to Provide Community Cancer Patients With Better, Faster Access to Cancer Trials

COLUMBUS, Ohio & BINGHAMTON, N.Y.--(BUSINESS WIRE)--Broome Oncology LLC and Deep Lens announced today ...
Read More

Kamala Maddali, DVM, PhD of Deep Lens Accepted into Forbes Business Council

Published on November 3, 2020 Forbes Business Council is an invitation-only community for successful business ...
Read More

PRA Health Sciences and Deep Lens announce strategic relationship to accelerate patient recruitment for precision cancer trials

Published on September 18, 2020 PRA Health Sciences and Deep Lens announce strategic relationship to ...
Read More

Deep Lens Announces Dr. Kamala Maddali Appointed to SCRS Oncology Board

COLUMBUS, Ohio--(BUSINESS WIRE)--Deep Lens announced today that Kamala Maddali, DVM, PhD, has been appointed ...
Read More

Could AI-Based Platform Offer Patients Options for Cancer Screenings and Trials?

VIPER from Deep Lens aims to rapidly and effectively match patients with precision therapies and clinical ...
Read More

Deep Lens partners with Franciscan Health to match oncology patients to clinical trials

Deep Lens Inc.’s artificial intelligence trial screening and enrollment platform, Viper, will be integrated ...
Read More

Franciscan Health, Deep Lens Collaboration Offers Personalized, Targeted Treatments

Published on August 20, 2020 New Platform Provides Patients Options for Cancer Screenings, Trials Franciscan ...
Read More

Deep Lens First to Integrate Cancer Genetic Data into AI Platform

Deep Lens First to Integrate Cancer Genetic Data into AI Platform to Rapidly Match Patients to Precision ...
Read More

Live panel: The new clinical ecosystem

Last week Kyle Flickinger took part in a panel discussion at EYEFORPHARMA PHILADELPHIA 2020.  The new ...
Read More

SCRS Welcomes Deep Lens to the Global Impact Partner Program

SCRS Welcomes Deep Lens to the Global Impact Partner Program Hanover, MD, March 31, 2020 – The Society for ...
Read More

Profile of a Founder - Dave Billiter

An exclusive Tech Tribune Q&A with Dave Billiter, the co-founder and CEO of Deep Lens, who was honored in ...
Read More

Deep Lens Named in 2020 Best Tech Startups in Ohio

The Tech Tribune staff has compiled the very best tech startups in Ohio. In doing their research, they ...
Read More

AI-Driven Technologies Poised to Improve Subject Recruitment in Oncology Clinical Studies

By The Editors at Uncommon Conversations, March 10, 2020 Advancements of artificial intelligence into pharma ...
Read More

Artificial Intelligence Technologies Support Clinical Operations in Oncology Studies

  By The Editors at Uncommon Conversations, March 5, 2020 As the pharmaceutical and medical care industries ...
Read More

Nanalyze: One of the 7 AI Healthcare Startups Automating Clinical Trials.

Recently Nanalyze featured Deep Lens in an article about 7 AI Healthcare Startups Automating Clinical Trials. ...
Read More

Deep Lens, Inc. Named to the 2019 CB Insights Digital Health 150

Deep Lens, Inc. recognized for achievements in Best Application of AI CB Insights today named Deep Lens, ...
Read More

Deep Lens recognized in 90+ Artificial Intelligence Startups In Healthcare

Learn how these top startups are applying AI in healthcare to discover new drugs, remotely monitor patients, ...
Read More

Kevin Whiteley Joins Deep Lens

Deep Lens Appoints Kevin Whiteley as Vice President of Provider Sales   COLUMBUS, Ohio, July 11, 2019  –  ...
Read More

Accelerating Oncology Trial Recruitment by Identifying Patients at Diagnosis

Published by The Association of Clinical Research Professionals on June 11, 2019 Clinical Researcher—June ...
Read More

$14 Million Series A Financing Secured

Deep Lens Closes $14 Million Series A Financing to Further Advance Digital AI Pathology Platform for Clinical ...
Read More

Worldwide Clinical Trials and Deep Lens Partnership

Worldwide Clinical Trials and Deep Lens Enter Strategic Alliance to Accelerate Recruitment and Development ...
Read More

Venture Beat's Article on the $3.2 Million raised by Deep Lens

Deep Lens raises $3.2 million for AI cloud pathology platform Author: Kyle Wiggers Dave Billiter, an Ohio ...
Read More

360Dx Article - Digital Pathology Startup Deep Lens Emerges

Digital Pathology Startup Deep Lens Emerges From Stealth Mode NEW YORK (360Dx) – Digital pathology startup ...
Read More

Fierce Biotech - Digital Pathology Startup Deep Lens launches with $3.2m

Digital pathology startup Deep Lens launches with $3.2m Author: Amirah Al Idrus In the more than 10 years ...
Read More

MedCityNews - Digital Pathology company exits stealth mode with $3.2m

Digital pathology company exits stealth mode with $3.2m in funding The startup, Deep Lens, is supported by ...
Read More

Deep Lens Executives and Advisory Board Press Release

Deep Lens Announces Expanded Executive Team and Advisory Board New appointments come as the company launched ...
Read More